PFM Health Sciences, LP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 1 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2018$3,235,000
-81.0%
66,967
-93.5%
0.07%
-87.2%
Q2 2016$17,069,000
+44.8%
1,028,867
+38.5%
0.52%
+41.9%
Q1 2016$11,784,000
-48.2%
742,986
+5.5%
0.36%
-47.5%
Q4 2015$22,760,000
-28.9%
703,987
-7.2%
0.69%
-23.1%
Q3 2015$31,992,000758,8160.90%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders